Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.12), $0.10 better than the analyst estimate of ($0.22). Revenue for the quarter ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE